Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
Patents for C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
12/2003
12/30/2003US6670348 Antitumor geldanamycins
12/24/2003WO2003106653A2 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
12/24/2003WO2003106390A1 Polymerisation inhibitor
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
11/2003
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220295 Epothilone derivatives
11/25/2003US6653469 Contacting mixture of geldanamycin and fluid comprising supercritical carbon dioxide
11/20/2003WO2003014105A9 Bicyclic compound, production and use as hiv inhibitors
11/20/2003US20030216369 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
10/2003
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/15/2003CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy
10/02/2003WO2003026571A3 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
10/02/2003US20030186394 Fermenting, separating and recovering geldanamycin from streptomyces hygroscopicus
09/2003
09/18/2003WO2003076478A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
09/18/2003WO2003076411A1 Process for producing optically active sulfoxide derivative
09/18/2003CA2479071A1 Process for producing optically active sulfoxide derivative
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/12/2003WO2002002488A9 Methods and compounds for modulating nuclear receptor coactivator binding
09/04/2003WO2003072794A1 Process to prepare and isolate geldanamycin
09/04/2003CA2476658A1 Process to prepare and isolate geldanamycin
08/2003
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/12/2003US6605599 Epothilone derivatives
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
07/2003
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/15/2003US6593474 Adrenergic blocking agents
07/08/2003US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
07/03/2003WO2003053927A1 Piperazine derivative
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003CA2470808A1 Piperazine derivative
07/02/2003EP1323729A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof derivatives; and use in the synthesis of perindopril
07/02/2003EP1322609A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/02/2003EP1322325A1 Inhibiting hepatitis c virus processing and replication
07/02/2003EP1322307A1 Methods for treating cell proliferative disorders and viral infections
07/02/2003CN1427821A Method for producing cyclic lactams
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003US20030119833 Treating cardiovascular diseases
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114450 Benzoquinone ansamycins
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/18/2003EP1319668A1 Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/04/2003EP1315732A2 Radicicol and monocillin and their analogues and uses thereof
05/2003
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/22/2003WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/15/2003WO2002058679A3 Antiangiogenic compounds and an assay for inhibitors of cell invasion
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/08/2003WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/2003
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/03/2003WO2003026571A2 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
04/03/2003WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
04/03/2003CA2460498A1 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
04/02/2003EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding
03/2003
03/19/2003CN1404461A Process for producing cyclic compound
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
02/2003
02/27/2003US20030040632 Process for producing cyclic compound
02/20/2003WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors
02/20/2003WO2003013430A2 Benzoquinone ansamycins
02/20/2003CA2607992A1 Bicyclic compound, production and use thereof
02/20/2003CA2456175A1 Benzoquinone ansamycins
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/05/2003CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
02/04/2003US6514990 Pharmaceutically active compounds and methods of use
01/2003
01/31/2003WO2002007761A1 Inhibiting hepatitis c virus processing and replication
01/31/2003CA2416603A1 Inhibiting hepatitis c virus processing and replication
01/29/2003EP1278726A1 Method for producing cyclic lactams
01/07/2003US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria
01/02/2003US20030004149 Antiangiogenic compounds and an assay for inhibitors of cell invasion
12/2002
12/31/2002US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/18/2002EP1266881A1 Process for producing cyclic compound
12/11/2002EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/11/2002EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
11/2002
11/20/2002EP1258250A1 Nerve protective drugs
11/14/2002US20020169156 Azacyclooctane and heptane derivatives, their preparation and use in therapy
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17